On August 11, 2016, the 11th participant was enrolled in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness in Marin, Calif. Led by Principal Investigator Phil Wolfson, M.D., with co-therapist Julane Andries, LMFT, this study is gathering preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for treating anxiety in 18 subjects diagnosed with a life-threatening illness. “Our study is progressing—13 subjects now —with wonderful experiences and gratifying changes in awareness, reductions of fear, self-worth, and relationships,” reports Dr. Wolfson. “As our subjects have life-threatening illnesses, there is the unfortunate possibility of relapse or recurrence. With great sadness, we report the loss of one of our subjects to recurrent cancer. We are privileged to do this work in all its seriousness and great beauty.”
